Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shifa International Hospitals Buyback Yield % Chart
KAR:SHFA vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Shifa International Hospitals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shifa International Hospitals Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shifa International Hospitals's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Shifa International Hospitals's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shifa International Hospitals (KAR:SHFA) has a Buyback Yield % of 0.00 as of Jul. 16, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Shifa International Hospitals and its competitors. According to the industry distribution chart, Shifa International Hospitals ranks #999999 out of 273 companies in the Healthcare Providers & Services industry.
Is Shifa International Hospitals' Buyback Yield % too high?
Shifa International Hospitals' current Buyback Yield % is 0.00. Based on the distribution chart, Shifa International Hospitals ranks #999999 out of 273 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Shifa International Hospitals has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shifa International Hospitals' Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shifa International Hospitals ranks #999999 out of 273 companies for Buyback Yield %. This places Shifa International Hospitals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Shifa International Hospitals and its competitors. Shifa International Hospitals's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shifa International Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Shifa International Hospitals (KAR:SHFA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨458.67, compared to a current price of ₨522.64 — trading 13.9% above its estimated fair value. The current Buyback Yield % is 0.00. Shifa International Hospitals' overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Shifa International Hospitals (KAR:SHFA), the current Buyback Yield % is 0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shifa International Hospitals (KAR:SHFA) Overvalued in 2026?
Based on GuruFocus' analysis, Shifa International Hospitals stock appears to be overvalued.
The current stock price of ₨522.64 is trading 13.9% above its estimated GF Value™ of ₨458.67.
GuruFocus considers Shifa International Hospitals to be Modestly Overvalued.
Key valuation signals for KAR:SHFA:
Buyback Yield %: 0.00
GF Value™: ₨458.67 vs. price of ₨522.64 (13.9% above fair value)
No single metric tells the full story. See the KAR:SHFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shifa International Hospitals Business Description
Shifa International Hospitals Ltd operates a network of medical centers and hospitals in Pakistan, providing a wide range of medical and surgical services across various specialties. The company offers organ transplant services, including liver, kidney, bone marrow, and corneal transplants. It generates revenue through patient care services, diagnostics, pharmacy operations, and support services such as emergency care and outpatient clinics. Shifa also operates lab collection points, day care surgeries, and diagnostic centers. The company has a presence in multiple cities through hospitals, medical centers, and subsidiaries that support healthcare services and infrastructure development.
86GF Score
Get the complete analysis for KAR:SHFA
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:SHFA has been successfully added to your 
